T cell immunologists have to embrace the fact that B cell depleting therapies are active. One way is to focus on the B or the other way is to shoe-horn the T into the B.
T cell immunologists have to embrace the fact that B cell depleting therapies are active.
One way is to focus on the B or the other way is to shoe-horn the T into the B.
The best way is to create your hypothesis and test it and put it to the Sword or not or […]
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
T cell immunologists have to embrace the fact that B cell depleting therapies are active. One way is to focus on the B or the other way is to shoe-horn the T into the B. The best way is to create your hypothesis and test it and put it to the Sword or not or […]
Open the app view to save this story, compare related coverage, and continue from the same source.